Annually, nearly 2 million people in the U.S. become infected with bacteria that antibiotics can’t treat. Antimicrobial stewardship protects patients and reduces health care costs.
Violence in the health care setting is on the rise. Here is how The Joint Commission and health care organizations are addressing it.
Many states are strengthening regulations around medication compounding. A new Joint Commission certification for compounding pharmacies is intended to support compliance.
The Joint Commission debuts refreshed Speak Up™ program to educate and empower patients
Joint Commission cracks down on hand hygiene (subscription may be required)
The Joint Commission Journal on Quality and Patient Safety is a peer-reviewed journal on innovative thinking, strategies, and practices in improving quality and safety in health care.
Inside the Latest Issue
This month, the Journal features studies on anticoagulation across care transitions, suicide in hospitals, adverse events during moderate sedation, tests results follow-up in the ambulatory setting and more. Obtain access to the latest table of contents, abstracts and other supplemental materials.
Reducing Adverse Drug Events from Anticoagulants During Care Transitions
Anticoagulants, medications that keep the blood from clotting, are heavily prescribed and effective but have been identified as major contributors to adverse drug events (ADEs). A new article in the November 2018 issue of The Joint Commission Journal on Quality and Patient Safety details the work of an IPRO-convened task force of The New York State Anticoagulation Coalition to develop a list of requisite data elements (RDEs) to adequately manage the anticoagulants of patients new to care from a previous setting.
View the online guide to U.S. health care organizations accredited and certified by The Joint Commission.
Find facts about accreditation, certification, patient safety, and more.
Get answers to frequently asked questions.
Public Information Policy
Read our policy outlining what information is available to the public.
Access additional information for the media about The Joint Commission.